Cantai Therapeutics, Inc. — Form D/A
Cantai Therapeutics, Inc. of PHILADELPIA, PA, a company, filed a Form D amendment with the SEC on 2023-11-20. The offering totals $3.0M, of which $700K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-20
- Form: D/A
- Accession: 0001991732-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $700K
- Remaining: $2.3M
- Investors: 3
- Date of first sale: 2023-11-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-497690
Issuer
- Name: Cantai Therapeutics, Inc.
- CIK: 0001991732
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 3675 MARKET STREET, PHILADELPIA, PA, 19104
- Phone: 603-996-1218
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Joshua Brandt | Executive Officer | Philadelphia, PA |
| Errik Anderson | Director | Cambridge, MA |
| Errik Anderson | Executive Officer | Cambridge, MA |
| Joshua Brandt | Director | Philadelphia, PA |
| Ross Leimberg | Director | Philadelphia, PA |
| Ross Leimberg | Executive Officer | Philadelphia, PA |
| Geeta Vemuri | Director | Waltham, MA |
| Geeta Vemuri | Executive Officer | Waltham, MA |
| Errik B. Anderson | Executive Officer | Cambridge, MA |
| Getta B. Vemuri | Director | Philadelphia, PA |
| Getta B. Vemuri | Executive Officer | Philadelphia, PA |
Other filings by this issuer (3)
More